Publication | Open Access
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
33
Citations
8
References
2016
Year
ClinicalTrials.gov Identifier NCT01745822 .
| Year | Citations | |
|---|---|---|
Page 1
Page 1